Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1160

1.

Reversible Splenial Lesion Syndrome After Intravenous Immunoglobulin Treatment for Guillain-Barre Syndrome.

Uygur Kucukseymen E, Yuksel B, Genc F, Ozaydin Goksu E, Yildiz S, Bicer Gomceli Y.

Clin Neuropharmacol. 2017 Aug 14. doi: 10.1097/WNF.0000000000000236. [Epub ahead of print]

PMID:
28816832
2.

Guillain-Barré Syndrome and Chikungunya: Description of All Cases Diagnosed during the 2014 Outbreak in the French West Indies.

Balavoine S, Pircher M, Hoen B, Herrmann-Storck C, Najioullah F, Madeux B, Signate A, Valentino R, Lannuzel A, Saint Louis M, Cassadou S, Cabié A, Schepers K.

Am J Trop Med Hyg. 2017 Aug;97(2):356-360. doi: 10.4269/ajtmh.15-0753. Epub 2017 Jul 19.

PMID:
28722564
3.

Are Cerebrospinal Fluid Protein Levels and Plasma Neutrophil/Lymphocyte Ratio Associated with Prognosis of Guillain Barré Syndrome?

Sahin S, Cinar N, Karsidag S.

Neurol Int. 2017 Jun 23;9(2):7032. doi: 10.4081/ni.2017.7032. eCollection 2017 Jun 23.

4.

Clinical association: Lyme disease and Guillain-Barre syndrome.

Patel K, Shah S, Subedi D.

Am J Emerg Med. 2017 Jul 8. pii: S0735-6757(17)30559-4. doi: 10.1016/j.ajem.2017.07.030. [Epub ahead of print]

PMID:
28711274
5.

Unusual sensory variant of Guillain-Barré syndrome.

Semproni M, Gibson G, Kuyper L, Tam P.

BMJ Case Rep. 2017 Jul 14;2017. pii: bcr-2016-218935. doi: 10.1136/bcr-2016-218935.

PMID:
28710191
6.

Takotsubo cardiomyopathy with Guillain-Barré syndrome.

Gill D, Ruiz VG, Dean R, Liu K.

Proc (Bayl Univ Med Cent). 2017 Jul;30(3):307-308.

7.

Acute painful autoimmune neuropathy: A variant of Guillain-Barré syndrome.

Yuki N, Chan AC, Wong AHY, Inoue T, Yokai M, Kurihara T, Devaux JJ, Wilder-Smith E.

Muscle Nerve. 2017 Jul 1. doi: 10.1002/mus.25738. [Epub ahead of print]

PMID:
28667708
8.

Acute segmental poliomyelitis-like flaccid paralysis in an adult in the UK, associated with enterovirus D68.

Stacpoole SRL, Molyneux A, Bäumer D.

Pract Neurol. 2017 Aug;17(4):297-301. doi: 10.1136/practneurol-2017-001609. Epub 2017 Jun 16.

PMID:
28626021
9.

Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.

Delmont E, Manso C, Querol L, Cortese A, Berardinelli A, Lozza A, Belghazi M, Malissart P, Labauge P, Taieb G, Yuki N, Illa I, Attarian S, Devaux JJ.

Brain. 2017 Jul 1;140(7):1851-1858. doi: 10.1093/brain/awx124.

PMID:
28575198
10.

Acute Demyelinating Polyneuropathy as Presentation of Hereditary Neuropathy With Liability to Pressure Palsies in a Patient Who Exercised Regularly in the Army.

Perugula M, Uppal G, Chuquilin M.

J Clin Neuromuscul Dis. 2017 Jun;18(4):228-234. doi: 10.1097/CND.0000000000000145.

PMID:
28538254
11.

Hyponatremia in Guillain-Barré Syndrome.

Rumalla K, Reddy AY, Letchuman V, Mittal MK.

J Clin Neuromuscul Dis. 2017 Jun;18(4):207-217. doi: 10.1097/CND.0000000000000157.

PMID:
28538251
12.

Guillain-Barré Syndrome, variants & forms fruste: Reclassification with new criteria.

Hiew FL, Ramlan R, Viswanathan S, Puvanarajah S.

Clin Neurol Neurosurg. 2017 Jul;158:114-118. doi: 10.1016/j.clineuro.2017.05.006. Epub 2017 May 4.

PMID:
28514704
13.

Guillain-Barré syndrome in a patient with renal cell carcinoma following the first course of pazopanib therapy.

Koshikawa H, Tsukie T, Kurita A, Fujikura M, Suzuki M, Araki K.

J Infect Chemother. 2017 May 12. pii: S1341-321X(17)30104-6. doi: 10.1016/j.jiac.2017.04.014. [Epub ahead of print]

PMID:
28506529
14.

Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?-Reply.

Fokkink WR, Jacobs BC.

JAMA Neurol. 2017 Jul 1;74(7):872. doi: 10.1001/jamaneurol.2017.0566. No abstract available.

PMID:
28505236
15.

Could Albumin Be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?

Wang Y, Zhang HL.

JAMA Neurol. 2017 Jul 1;74(7):871-872. doi: 10.1001/jamaneurol.2017.0563. No abstract available.

PMID:
28505216
16.

Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis and Guillain-Barre Syndrome in a 16-Month-Old Child.

Matsui M, Shimizu M, Ioi A, Mayumi A, Higuchi K, Sawada A, Sato M, Yasui M, Yanagihara K, Inoue M.

Child Neurol Open. 2016 Apr 4;3:2329048X15620641. doi: 10.1177/2329048X15620641. eCollection 2016 Jan-Dec.

17.

Guillain-Barre Syndrome following Tuberculosis: A Rare Association.

Lakhotia AN, Chouksey D, Jain R, Sodani AK.

J Neurosci Rural Pract. 2017 Apr-Jun;8(2):296-299. doi: 10.4103/jnrp.jnrp_387_16.

18.

Incidence and clinical characteristics of Guillain-Barré syndrome before the introduction of Zika virus in Puerto Rico.

Salinas JL, Major CG, Pastula DM, Dirlikov E, Styczynski A, Luciano CA, Wojna V, Sharp TM, Sejvar JJ, Rivera-Garcia B.

J Neurol Sci. 2017 Jun 15;377:102-106. doi: 10.1016/j.jns.2017.04.006. Epub 2017 Apr 7.

PMID:
28477675
19.

Ipilimumab-induced Guillain-Barré Syndrome Presenting as Dysautonomia: An Unusual Presentation of a Rare Complication of Immunotherapy.

Kelly Wu W, Broman KK, Brownie ER, Kauffmann RM.

J Immunother. 2017 Jun;40(5):196-199. doi: 10.1097/CJI.0000000000000167.

PMID:
28452849
20.

Guillain-Barré syndrome in pregnancy: A case report.

Hukuimwe M, Matsa TT, Gidiri MF.

Womens Health (Lond). 2017 Apr;13(1):10-13. doi: 10.1177/1745505717704128. Epub 2017 Apr 25.

PMID:
28438080

Supplemental Content

Loading ...
Support Center